Table 4.
Mean SDS Score Across Sociodemographic Groups
| SDS Summary Measure | Male | Female |
|---|---|---|
| Observations (N) | 4892 | 629 |
| Mean | 28.8 | 35.5 |
| SD | 20.7 | 24.2 |
| Min | 0 | 0 |
| Max | 100 | 100 |
| p-value† | M:F <0.001† | |
| p-value‡ (Adjusted) | M:F <0.001‡ |
| SDS Summary Measure | White | Black | Hispanic | Other |
|---|---|---|---|---|
| Observations (N) | 3905 | 971 | 430 | 215 |
| Mean† | 29.8 | 28.5 | 29.2 | 30.4 |
| SD | 20.8 | 22.6 | 21.5 | 22.3 |
| Min | 0 | 0 | 0 | 0 |
| Max | 100 | 100 | 88.8 | 85 |
| p-value† | B:W <0.001† | B:H <0.001† | ||
| p-value‡ (Adjusted) | B:W <0.001‡ | B:H =0.003‡ |
| SDS Summary Measure | <HS | HS | Some College | College Grad | Post- Graduate |
|---|---|---|---|---|---|
| Observations (N) | 303 | 1055 | 1521 | 1561 | 776 |
| Mean† | 37.9 | 32.7 | 30.5 | 25.3 | 26.3 |
| SD | 24.2 | 23.3 | 21.1 | 18.9 | 19.3 |
| Min | 0 | 0 | 0 | 0 | 0 |
| Max | 100 | 95 | 95 | 100 | 100 |
| p-value† | <0.001 | <0.001 | <0.001 | ns | Reference |
| p-value‡ (Adjusted) | N=3267, β= −2.19; F =42.30 (7,3259); p < 0.001 | ||||
†
Student’s T-Test
‡
Adjusting for age and baseline measures.
Definitions: HIV-1 RNA viral load results were closest to baseline, defined as 0 – 90 days prior to baseline log transformed, continuous. CD4 results were closest to baseline, defined as 0 – 90 days prior to baseline (cells/μl), continuous. Duration of ART prior to baseline (months), (continuous, naïve patients have zero months). Baseline exposure to antiretroviral therapy is defined as naïve to ART, ART-experienced and currently on therapy, or ART-experienced and not currently on therapy. AIDS-defining event (clinical diagnosis) at baseline, dichotomous, 0 = no, 1 = yes)